Salisbury Adam C, Sapontis James, Saxon John T, Gosch Kensey L, Lombardi William L, Karmpaliotis Dimitri, Moses Jeffery W, Qintar Mohammed, Kirtane Ajay J, Spertus John A, Cohen David J, Grantham J Aaron
Department of Cardiovascular Medicine, Saint Luke's Mid America Heart Institute, Kansas City, Missouri; University of Missouri-Kansas City, Kansas City, Missouri.
Division of Cardiovascular Medicine, Department of Medicine, Monash Heart Hospital, Melbourne, Victoria, Australia.
Am J Cardiol. 2018 Mar 1;121(5):558-563. doi: 10.1016/j.amjcard.2017.11.024. Epub 2017 Dec 11.
Stress testing is endorsed by the American College of Cardiology/American Heart Association Appropriate Use Criteria to identify appropriate candidates for Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI). However, the relation between stress test risk classification and health status after CTO PCI is not known. We studied 449 patients in the 12-center OPEN CTO registry who underwent stress testing before successful CTO PCI, comparing outcomes of patients with low-risk (LR) versus intermediate to high-risk (IHR) findings. Health status was assessed using the Seattle Angina Questionnaire Angina Frequency (SAQ AF), Quality of Life (SAQ QoL), and Summary Scores (SAQ SS). Stress tests were LR in 40 (8.9%) and IHR in 409 (91.1%) patients. There were greater improvements on the SAQ AF (LR vs IHR 14.2 ± 2.7 vs 23.3 ± 1.3 points, p <0.001) and SAQ SS (LR vs IHR 20.8 ± 2.3 vs 25.4 ± 1.1 points, p = 0.03) in patients with IHR findings, but there was no difference between groups on the SAQ QoL domain (LR vs IHR 24.8 ± 3.4 vs 27.3 ± 1.6 points, p = 0.42). We observed large health status improvements after CTO PCI in both the LR and IHR groups, with the greatest reduction in angina among those with IHR stress tests. Although patients with higher risk studies may experience greater reduction in angina symptoms, on average, patients with LR stress tests also experienced large improvements in symptoms after CTO PCI, suggesting patients with refractory symptoms should be considered appropriate candidates for CTO PCI regardless of stress test findings.
负荷试验得到了美国心脏病学会/美国心脏协会合理使用标准的认可,用于识别慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)的合适候选人。然而,负荷试验风险分类与CTO PCI术后健康状况之间的关系尚不清楚。我们在12个中心的开放CTO注册研究中纳入了449例患者,这些患者在成功进行CTO PCI之前接受了负荷试验,比较了低风险(LR)与中高风险(IHR)结果患者的结局。使用西雅图心绞痛问卷心绞痛频率(SAQ AF)、生活质量(SAQ QoL)和综合评分(SAQ SS)评估健康状况。40例(8.9%)患者的负荷试验为LR,409例(91.1%)患者的负荷试验为IHR。IHR结果患者的SAQ AF(LR组与IHR组分别为14.2±2.7与23.3±1.3分,p<0.001)和SAQ SS(LR组与IHR组分别为20.8±2.3与25.4±1.1分,p=0.03)有更大改善,但两组在SAQ QoL领域无差异(LR组与IHR组分别为24.8±3.4与27.3±1.6分,p=0.42)。我们观察到LR组和IHR组在CTO PCI术后健康状况均有大幅改善,IHR负荷试验患者的心绞痛减轻最为明显。虽然风险较高研究的患者心绞痛症状可能减轻得更多,但平均而言,LR负荷试验患者在CTO PCI术后症状也有大幅改善,这表明无论负荷试验结果如何,有难治性症状的患者都应被视为CTO PCI的合适候选人。